diskarte sa fortune gems
PTI founder, Nawaz Sharif, Zardari should sit together for Pakistan, says Rana Sana
Medalist Diversified REIT CFO Winn buys $3,645 in stockAP News Summary at 2:48 p.m. ESTSaudi Arabia banned film for 35 years. The Red Sea festival is just one sign of the industry's riseApple slams Meta's numerous interoperability requests
NoneVANCOUVER, BC / ACCESSWIRE / December 6, 2024 / Marvel Discovery Corp. (TSXV:MARV)(FSE:O4T)(OTCQB:MARVF) ("Marvel" or the "Company") is pleased to announce its return to both its Blackfly Gold Project in Ontario and its Duhamel Nickel-Copper-Cobalt Project in Quebec. As part of this realignment, Marvel will not proceed with its Athabasca Basin uranium property options but will retain its high-potential uranium assets, including Elliott Lake, Pecors West, and East Bull in Ontario. This will better enable the Company to shift resources to our more advanced stage projects where better infrastructure and lower operating costs are established to advance them. Strategic Focus on Blackfly Gold and Duhamel Projects The Blackfly Gold Project, located in the prolific gold mining region near Atikokan, Ontario, has demonstrated strong potential with significant historical gold mineralization. Meanwhile, the Duhamel Nickel-Copper-Cobalt Project in Quebec represents a promising critical mineral opportunity amid growing global demand for battery metals. "The junior resource sector has experienced significant challenges over the past few years, and our focus is to streamline operations and target projects with the highest potential for success," said Karim Rayani, CEO of Marvel Discovery Corp. "Blackfly Gold and Duhamel offer exactly that - advanced-stage opportunities in regions where permitting is accessible and operational costs can be minimized, allowing us to deliver meaningful results efficiently." Blackfly Gold Project Highlights: Located in a historically significant gold region near Atikokan, Ontario, adjacent to the Hammond Reef Gold Deposit held by Agnico Eagle. High-grade gold assays from prior work, with visible gold in drill core (Figure 1) . Proximity to infrastructure and established mining operations, historical exploration, and recent fieldwork. Figure 1. Specks of visible gold in hole BF21-19 drilled at the Black Fly Northeast Zone. NQ core of a diameter of 47.6mm. Duhamel Nickel-Copper-Cobalt Project Highlights: Situated in Quebec, a mining-friendly jurisdiction with robust infrastructure. Potential for critical minerals, including nickel, copper, and cobalt, crucial for the transition to a green economy. Historical and recently completed exploration by Marvel pointing to potential significant mineralization. Refocusing to Drive Shareholder Value By discontinuing the Athabasca Basin uranium projects, Marvel is redirecting its resources to high-impact exploration at Blackfly and Duhamel. This decision positions the Company to better navigate the challenging market environment and capitalize on emerging opportunities in gold and critical metals while reducing operating costs and reducing shareholder dilution. Karim Rayani added: "This strategic pivot reflects Marvel's long-term vision of creating shareholder value through targeted exploration and disciplined project management. By focusing on projects with manageable costs and favorable permitting conditions, we are well-positioned to advance our portfolio and deliver results." Blackfly Atikokan Ontario, The Property is located in the developing Atikokan gold mining camp along and within the Marmion Fault Zone, approximately 13.6 kilometers ("km") southwest of Agnico Eagle's Hammond Reef Gold Deposit. The Blackfly Main Zone area and the Blackfly Northeast Zone occur in areas of magnetic lows along a property-wide, strong, linear northeast trending magnetic high that corresponds with a magnetic mafic dike. Gold is associated with strong silica-sericite-ankerite-pyrite ± chlorite alteration hosted within aquartz-veined granodiorite that has undergone shearing and deformation. Accessory sulphide phases include galena, chalcopyrite and bornite. Surface sampling, mapping and interpretation of magnetic data by Marvel has resulted in better defined and wider gold intervals than drilling by TerraX between 2009 and 2012. Assessment file records indicate that the original Blackfly gold discovery was made in 1897, making the occurrence one of the earliest found in the Atikokan gold mining camp. The project's 45-foot shaft was sunk in 1898 shortly after gold was discovered. Several companies have added to the database of the Property including: Rebair Gold Mines Ltd. (1945 to 1948), Steeprock Mines Ltd. (1949 and again in 1961), Aavdex Corporation (2004) and TerraX Minerals Inc. (2009 to 2012). Blackfly Drill Result from 2021 Drill Program Please see press release dated November 10, 2021.Vancouver, B.C Duhamel Nickel Copper Cobalt - Project Quebec: Located 350 km north of Quebec City, the Duhamel Ni-Cu-Co project lies between two prominent deformation zones in the central part of the Grenville Geological Province (Figure 2). The Duhamel Property is characterized by the presence of large mafic to ultramafic intrusive rock bodies located in northern margin of the Saguenay-Lac-Saint-Jean (SAGLSJ) Anorthosite Suite, one of the largest anorthosite intrusive bodies in the world. The Chute-des-Passes-Pipmuacan reservoir areas contains numerous massive sulfide and iron oxide mineralization occurrences recognized and documented by the Quebec government (Sigeom, Figure 2). Figure 2. Ni-Cu-Co and Fe-Ti-P-V mineral occurrences on the Chute-des-Passes and Pipmuacan Areas (modified from Hebert et Cadieux, 2002) The Duhamel Property currently contains seven (7) occurrences of Ni-Cu-Co sulphides and one (1) Fe-Ti-V iron oxide occurrence discovered between 1997 to 2001 by previous operators who defined a 13 km long mineralized rock corridor (Figure 3). Drill intercept highlights include 1.27% Ni, 0.33% Cu, and 0.12% Co over 3.0 meters by Virginia Gold Mines in 2000 that contained massive sulfides. Compilation of historic assessment reports to date reveals more than thirty (30) Ni-Cu (Co) and four (4) Fe-Ti (V, Cr) mineral occurrences which confirms this corridor to be highly prospective for new Ni-Cu-Co discoveries, as well as Fe-Ti (Cr, V) discoveries. Figure 3. Regional geology, structure, and mineral occurrences of the Duhamel property, included significant mineralized intervals of 2000 and 2001 diamond drilling programs (Ref. SIGEOM-MERNQ) Compilation of historical data by Marvel uncovered a grab sample from massive iron-titanium oxides that returned 0.28% V2O5 associated with 20.8% TiO2 and 0.13% Cr203. Pecors West property, Located in the heart of the Elliott Lake Ontario historical uranium camp the Pecors West property has the potential to host three unique styles of mineralization under the critical metals criteria: PGM-Ni-Cu magmatic style mineralization associated with the large Pecors regional magnetic anomaly. Uranium mineralization typical of the Elliot Lake uranium camp within the Pecors Channel. Uranium and rare-earth oxide (REO) mineralization similar to the contiguous Radio Fuels Eco Ridge Project. The Pecors West property is strategically located next door to an inferred resource of 20,000,000 tons grading 0.037% (0.74 lbs./t) U3O8 or 14,800,000 lbs. U3O8 defined by limited drilling by Rio Algom in1977) . This uranium mineralization is hosted within the Pecors Channel now held by Power One Resources (a spinout from Marvel Discovery). This resource estimated is based on limited drilling and there is potential to expand the Pecors Channel onto the Pecors West property. Uranium is hosted within the quartz-pebble conglomerate of the Matinenda Formation at shallow depths within the Pecors Channel. ‘Channels' within the Elliot Lake uranium camp were mined extensively in the 1950s where production grades averaged 0.100% U3O8. The resource estimate cited above predates and therefore does not conform to the more stringent reporting requirements of National Instrument 43-101 and should not be relied upon according to those standards. Marvel has not yet done exploration work to verify or classify the historical estimates as a current mineral resource, and the Company is not treating the historical estimates as a current mineral reserve or resource. The Company is currently reviewing all historical and data from its most recent exploration programs to define its second phase of drilling both at the Blackfly and Duhamel Projects planned for early next year. Qualified Person Mike Kilbourne, P. Geo, an independent qualified person ("QP") as defined in National Instrument 43-101, has reviewed, and approved the technical contents of this news release on behalf of the Company. About Marvel Discovery Corp. Marvel Discovery Corp. is a Canadian resource company focused on generating and developing mineral exploration projects in gold, base metals, critical minerals, and uranium. With a diversified portfolio across Canada, Marvel remains committed to sustainable exploration practices and creating long-term shareholder value. Atikokan, Ontario (Blackfly - Au Prospect) Elliot Lake, Ontario (Pecors West & East Bull Ontario - Ni-Cu-PGE Prospect) Quebec, (Duhamel -Ni-Cu-Co prospect & Titanium, Vanadium, and Chromium Prospect) Newfoundland, (Hope Brook Critical Elements & Lithium Prospect, and Victoria Lake Prospect) Prince George, British Columbia (Wicheeda North - Rare Earth Elements Prospect) The Company's website is: ON BEHALF OF THE BOARD Marvel Discovery Corp. "Karim Rayani" Karim Rayani President/Chief Executive Officer, Director Tel: 604 716 0551 email: Disclaimer for Forward-Looking Information: Certain statements in this release are forward-looking statements which reflect the expectations of management. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward-looking statements in this press release relate to, among other things: completion of the proposed Arrangement. Actual future results may differ materially. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times. Except as required by law, the Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE: Marvel Discovery Corporation View the original on
BRUSSELS (Reuters) – Apple on Wednesday hit out at Meta Platforms, saying its numerous requests to access the iPhone maker’s software tools to its devices could impact users’ privacy and security, underscoring the intense rivalry between the two tech giants. Under the European Union’s landmark Digital Markets Act that took effect last year, Apple must allow rivals and app developers to inter-operate with its own services or risk a fine of as much as 10% of its global annual turnover. Meta has made 15 interoperability requests thus far, more than any other company, for potentially far-reaching access to Apple’s technology stack that could affect users’ privacy and security, the latter said in a report. (Reporting by Foo Yun Chee; Editing by Chris Reese) Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );None
Nebraska's Matt Rhule: 'Total overhaul' of special teams coming after Pinstripe Bowl disaster
Medalist Diversified REIT CFO Winn buys $3,645 in stockMercer, a global leader in workforce and investment solutions, released its 2024 Quality of Life Cities ranking, evaluating 241 cities for living conditions suited to international assignees and their families. Santo Domingo placed 167th globally, reflecting ongoing challenges in public services and transportation. In Latin America, Montevideo leads the region at 92nd, followed by San Juan (95th), Buenos Aires (97th), and Santiago (98th). Notably, Mexico City showed significant improvement, climbing 14 positions to 116th. Zurich, Switzerland, claimed the top spot globally due to its robust infrastructure, safety, cultural vibrancy, and sustainability initiatives. Other top-ranked cities include Vienna (Austria), Geneva (Switzerland), Copenhagen (Denmark), and Auckland (New Zealand). European cities dominate the top ten, solidifying the continent’s appeal to international assignees. Mercer emphasized the importance of assessing factors like political stability, social environment, and cost implications for expatriates. According to Yvonne Traber, Mercer’s Global Mobility Leader, companies must prioritize quality of life and affordability to manage global mobility effectively. Latin American cities continue to grow in attractiveness for international mobility, offering natural beauty, recreational options, and competitive costs despite infrastructural hurdles.
IRVINE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE TechnologyTM (SmartPath)—the industry’s first tissue-to-digitalTM imager using MUSE (Microscopy with Ultraviolet Surface Excitation) technology, intended to create a solution that eliminates the need for traditional slide-based histology, a fundamental process that has remained unchanged for over a century. SmartPath’s objective of this advanced imager is to provide new technology that rapidly captures high-resolution ultraviolet images, directly from whole fresh or formalin-fixed (non-FFPE) tissue, and convert these UV images to detailed H&E-like digital images for pathologist’s review. Utilization of non-caustic fluorescent dyes on fresh tissue significantly improves RNA retained in the sample for downstream processing. This first of its kind imager implements a simple workflow, with the goal of bringing unprecedented efficiency to aid pathologists in diagnostic pathology labs worldwide. By eliminating cumbersome manual processes, SmartPath has the potential to propel pathology into the digital age and support a wide range of global IVD applications and market segments. Matthew Nuñez, CEO of MUSE Microscopy, Inc., expressed the company’s enthusiasm about this landmark achievement: “We are immensely proud of the advancements we’ve made with SmartPath—a groundbreaking tissue-to-digital imager that redefines where true digital pathology starts. This moment signifies more than just a new product; it represents the potential for a fundamental transformation for the entire field of pathology, empowering professionals to move past legacy processes that have constrained advancements in workflow and diagnostics for far too long. With SmartPath, we are intent on setting a new standard and opening doors to the next generation of aids in pathology.” Transforming a Long-Standing Pathology Workflow The SmartPath Imager tackles one of pathology’s most persistent challenges: the dependence on traditional glass slide histology. By leveraging rapid tissue-to-digital imaging technology, SmartPath seeks to transform pathology, from analog slide-based processes to a seamless and effective workflow that provides high-resolution digital tissue images to pathologists, without destructive direct-to-digital sample preparation. The statements made regarding the SmartPath Imager have not been evaluated by the Food and Drug Administration (FDA). The SmartPath System is currently intended for research use only. This medical device has not yet been evaluated or cleared by the FDA. Its safety and effectiveness have not been established nor confirmed by FDA-approved research. SmartPath is not currently available for sale in the United States as a diagnostic aid or medical device for human pathology. This material is provided solely for informational purposes and does not substitute for professional medical advice. It also does not constitute an offer to promote the device for any medical use. About MUSE Microscopy, Inc. MUSE Microscopy, Inc. is a company that specializes in the application of Microscopy with Ultraviolet Surface Excitation (MUSE). We are developing a MUSE-enabled imaging system for diagnostic assistance in pathology, cytology, and research applications. SmartPath MUSE TechnologyTM (SmartPath), is intended to be a slide-free tissue-to-digital imaging platform that aims to revolutionize digital pathology by eliminating the need for traditional slide-based histology. Our goal is to offer a first-to-market, non-destructive tissue imaging solution. To learn more, you can visit their website at https://musemicroscopy.com/ or find them on social media platforms such as X, Facebook, and LinkedIn. Limits on Accuracy This press release is intended to provide information about MUSE Microscopy, Inc.’s research and potential product. Information is believed to be accurate at the time it is created. However, like any printed material, information may become outdated over time. Information may contain technical inaccuracies or typographical errors. Information may be changed or updated without notice. There may also be improvements or changes in the products and services described in this press release at any time without notice. It is important that you rely on the advice of an appropriate professional. Nothing contained in any presentation is to be construed as medical, legal, investment, financial, or other advice. This information is not intended to be a substitute for such advice. MUSE Microscopy, Inc. does not endorse any specific techniques or methods of treatment. Individuals are advised to consult their health care professionals for full information about the potential adverse reactions from use of the medical technologies discussed in this press release. We will use reasonable efforts to include accurate and up-to-date information on the website, but MUSE Microscopy, Inc. makes no warranties or representations as to its accuracy. Forward-Looking Statements Forward-looking statements in this press release are based on our future expectations, plans prospects, and assumptions regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. The words “termed,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Any forward-looking statement made by us in this document speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by law. CONTACT: Matthew Nuñez Tel: 949.813.6121 mnunez@musemicroscopy.com Source: MUSE Microscopy, Inc.None
USDA Orders Testing of Milk Supply for Presence of Bird Flu Virus
Barrister cleared of misconduct calls on head of Bar Standards Board to resign